Expert Clinical Consulting Services for CROs and Biotech Companies
Are you a CRO?
We are currently partnered with 31 of the top 40 CROs in the world who have operations within North America. We guide CROs and clinical vendors to develop better and more strategic client proposals, messaging, and solutions during the pre-award stage to maximize contracted new gross revenue with their biotech leads in the early-phase and FIH oncology space.
Are you a Biotech?
We are early-phase and FIH oncology specialists. We guide pre-clinical and clinical stage biotechnology companies through their entry into the clinic, reducing errors, delays, and total cash burn, and ensuring the choices of the best-fit CRO and vendors for their outsourcing needs.
CROs – Maximize New Revenue
Specialized in optimizing your business workflows, client-facing materials, and team training for delivery of optimal deliverables at the request for proposal stage (proposals, budgeting, bid defenses) to your potential clients to maximize contracted new business revenue.
Biotechs – Oncology Strategy from Experience
Specialized in pre-study country-site-patient strategic feasibility for early-phase and first-in-human oncology protocols, in addition to oncology clinical trial strategy, planning, startup, and conduct.
CROs – Differentiate Your Knowledge
Specialized in early-phase and first-in-human oncology clinical protocol review and clinical trial design optimization based on current clinical landscape, IMP mechanism of action, estimated enrollment performance, standard of care, and expected competition for site and KOL resources.
Biotechs – Process Excellence from Experience
Specialized in vendor-facing messaging and communications, RFP teams, strategy, and process management, overall strategy, and CRO qualification for early-phase and first-in-human oncology clinical trial launches.
Our Experience
Founder’s Expertise
Dr. Nathan Currier, the CEO and Founder of Currier Clinical Consulting Inc, possesses over 28 years of experience in the clinical development, pre-clinical development, clinical research, and biotechnology sectors, including 12 years as a subject matter expert (SME) in the clinical research organization (CRO) industry. His PhD is in cellular and molecular biology from McGill University and he has spent the last 28 years focused on oncology, commercial strategy, and clinical research.
Key Experience
- Oncology clinical strategy executive. Commercial account strategist. Therapeutic subject matter expert.
- 28+ years of oncology research (academic, fundamental, pre-clinical, clinical, executive oversight) experience.
- PhD in cellular and molecular biology with an academic research focus in NK-cell-mediated amelioration of a rare form of acute myeloid leukemia (Di Guglielmo Syndrome – erythroleukemia).
- Extensive solid tumor and heme/onc experience. Pediatric oncology experience in neuroblastoma with radioligand moieties.
- Lead therapeutic subject matter expert on over 400 oncology client proposals (RFPs) over the past decade, reviewing over 300 oncology clinical protocols during that time. Lead strategy oncology SME on over 120 client bid defense meetings.
- Early-phase clinical oncology specialist (15+ years).
- Guidance to CROs on RFP strategy and conduct, budget strategy, client messaging and communications strategy, bid defense strategy and preparation, and team coaching. Protocol review and optimization.
- Clinical study design.
- Study feasibility and country/site/patient optimization, clinical competitive landscape analysis.
- Patient recruitment and retention planning.
- Study endpoint and data needs analysis.
- Medical education experience.
With a robust background in oncology, Dr. Currier’s expertise as an SME in navigating the complex, dynamic, global clinical trial landscape ensures that both CRO and biotech clients receive the highest level of guidance and support.
Our Clinical Consulting Mission and Vision
Currier Clinical Consulting Inc is committed to delivering unparalleled clinical consulting services to CROs and small and medium biotechnology companies. Our mission is to empower these businesses with the insights and expertise they need to thrive in the competitive clinical trial landscape, with the critical success factor being the improvement of quality of life for patients with cancer. We envision a future where our clients lead the industry in innovation and success, supported by our dedicated partnership and strategic clinical consulting guidance.
Connect with us on LinkedIn
Nathan Currier, PhD – CEO and Founder
